Реакция #1605838

ord-e5b93531abba434288b685171e84abd3

Уравнение реакции

O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
aripiprazole
CC(C)(C)C(=O)Cl
pivaloyl chloride
CC(C)(C)C(=O)OC1=Nc2cc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)ccc2CC1
title compound
CC(C)(C)C(=O)OC1=Nc2cc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)ccc2CC1
7-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-3,4-dihydroquinolin-2-yl pivalate

Реагенты

Растворители

Условия реакции

Температура
0°CELSIUS
Подробные условия
See reaction.notes.procedure_details.

Обработка

  1. 1
    Температураto warm to room temperature
  2. 2
    ТемператураAfter a further 5 minutes the temperature was increased to 50° C. for approximately 19 hours
  3. 3
    Температураto cool to room temperature
  4. 4
    ДругоеThe two reaction mixtures
  5. 5
    Другоеquenched with approximately methanol (5 mL)
  6. 6
    ДругоеThe majority of the pyridine was removed in vacuo
  7. 7
    Другоеthe residue partitioned between dichloromethane (30 mL) and saturated NaHCO3 solution (30 mL)
  8. 8
    ЭкстракцияThe aqueous phase was extracted with dichloromethane (2×30 mL)
  9. 9
    Промывкаthe combined organic extracts washed with brine (20 mL)
  10. 10
    Сушкаdried over MgSO4
  11. 11
    ФильтрацияAfter filtration
  12. 12
    Другоеthe volatiles were removed (toluene and methanol/dichloromethane azeotrope)
  13. 13
    Другоеthe residue purified by silica chromatography
  14. 14
    Промывкаeluting first with dichloromethane

Методика

To a stirred solution of aripiprazole (0.1 g, 0.223 mmol) in pyridine (1 mL) at 0° C. was added pivaloyl chloride (0.055 mL, 0.446 mmol). After stirring at 0° C. for 5 minutes the reaction was allowed to warm to room temperature. After a further 5 minutes the temperature was increased to 50° C. for approximately 19 hours. The reaction was allowed to cool to room temperature. The reaction was repeated in a similar manner using of aripiprazole (1.75 g, 3.90 mmol). The two reaction mixtures were combined and quenched with approximately methanol (5 mL). The majority of the pyridine was removed in vacuo and the residue partitioned between dichloromethane (30 mL) and saturated NaHCO3 solution (30 mL). The aqueous phase was extracted with dichloromethane (2×30 mL) and the combined organic extracts washed with brine (20 mL) and dried over MgSO4. After filtration, the volatiles were removed (toluene and methanol/dichloromethane azeotrope) and the residue purified by silica chromatography eluting first with dichloromethane followed by ethyl acetate/dichloromethane/methanol (1:1:0.04) to give the title compound (1.19 g, 54%).

Источник

DOI: 10.6084/m9.figshare.5104873.v1Патент: US09072788B2uspto-grants-2015_07